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Background: Acute seizures are common among children admitted to hospitals in resource poor countries.
However, there is little data on the burden, causes and outcome of neonatal seizures in sub-Saharan Africa. We
determined the minimum incidence, aetiology and immediate outcome of seizures among neonates admitted to a
rural district hospital in Kenya.
Methods: From 1
st January 2003 to 31
st December 2007, we assessed for seizures all neonates (age 0-28 days)
admitted to the Kilifi District Hospital, who were resident in a defined, regularly enumerated study area. The
population denominator, the number of live births in the community on 1 July 2005 (the study midpoint) was
modelled from the census data.
Results: Seizures were reported in 142/1572 (9.0%) of neonatal admissions. The incidence was 39.5 [95%
confidence interval (CI) 26.4-56.7] per 1000 live-births and incidence increased with birth weight. The main
diagnoses in neonates with seizures were sepsis in 85 (60%), neonatal encephalopathy in 30 (21%) and meningitis
in 21 (15%), but only neonatal encephalopathy and bacterial meningitis were independently associated with
seizures. Neonates with seizures had a longer hospitalization [median period 7 days - interquartile range (IQR) 4 to
10] -compared to 5 days [IQR 3 to 8] for those without seizures, P = 0.02). Overall, there was no difference in
inpatient case fatality between neonates with and without seizures but, when this outcome was stratified by birth
weight, it was significantly higher in neonates ≥ 2.5 kg compared to low birth weight neonates [odds ratio 1.59
(95%CI 1.02 to 2.46), P = 0.037]. Up to 13% of the surviving newborn with seizures had neurological abnormalities
at discharge.
Conclusion: There is a high incidence of neonatal seizures in this area of Kenya and the most important causes
are neonatal encephalopathy and meningitis. The high incidence of neonatal seizures may be a reflection of the
quality of the perinatal and postnatal care available to the neonates.
Background
The first month of life is one of the highest risk periods
for seizures [1] and seizures are the most common man-
ifestation of neurological conditions in the neonate [2].
Neonatal seizures have been shown to be a major risk
factor for inpatient death and subsequent neurological
disability [3-5]. They show marked differences from sei-
zures in older age groups: tonic-clonic seizures,
common in children and adults, are rarely seen in the
neonate [6] and electro-clinical dissociation [that is, sei-
zure activity on electroencephalography (EEG) without
clinically observed manifestations] are more common in
neonates than in other age groups [7]. These differences
can result in either over or under-estimation of the inci-
dence of neonatal seizures [8]. In addition, the advance-
ment in the treatment of neonatal seizures has changed
little compared to seizures in the older population. Phe-
nobarbital, introduced in 1914, remains the drug of
choice especially in resource-poor settings [9,10].
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that most ictal events are secondary to acute neurologi-
cal insults such as hypoxic ischaemic encephalopathy
(HIE), stroke or infection [5,11]. In sub-Saharan Africa,
HIE has also been strongly associated with many cases
of early-onset neonatal seizures [12]. However, the pre-
sence of the identified risk factors for HIE, such as pH
<7, Apgar score <5 at 5 min and the requirement for
intubation, have proved to be unreliable predictors of
neonatal seizures in this region [13]. In the short term,
s e i z u r e si nt h en e o n a t em a yb ea s s o c i a t e dw i t hh i g h e r
inpatient death and prolonged inpatient stay [12,14]. In
the long term, neonatal seizures are associated with an
increased risk of neuro-disability including epilepsy, cer-
ebral palsy and delayed neurodevelopment [4,15-17].
Although neonatal seizures are a common problem in
hospitalized neonates in the region [12,18,19], few Afri-
can studies have examined the burden and causes of sei-
zures or the outcomes of treatment. The higher rates of
neonatal encephalopathy, neonatal sepsis and premature
births in developing countries [20] suggest that the inci-
dence may be much higher than that reported in the
West. In Ethiopia, one hospital based study found an
incidence of 13.6 per 1000 live births [12]. More
recently, in a study in which we examined the aetiology
of acute seizures in Kenyan children, the incidence was
found to be highest during the neonatal period [14]. In
the current study, we recruited all neonates from the
same defined geographical area of coastal Kenya hospi-
talized with seizures over a 5-year period in order to




Since 1998 we have conducted continuous inpatient sur-
veillance aimed at describing the causes and features of
common illnesses among Kenyan children in the Kilifi
District Hospital [21,22]. The hospital is located within
the Kilifi epidemiology and demographic surveillance
system (EPI-DSS). This is a system where a resident
population of over 240,000 living within a catchment
area of 891 km
2 is continuously monitored and vital
events updated every 4 months. The entire area was
mapped using global positioning system and both map-
ping and population data are linked on-line to the hos-
pital admission data.
Standardized clinical and laboratory data is prospec-
tively collected on admission and at discharge or death
by clinical and medical officers and directly entered into
a computer database. For this analysis, we used data for
patients admitted over a 5-year period from 1
st January
2003 through to 31
st December 2007, since this is the
period during which we had reliable data. Consent for
use of the data was obtained from the guardian of every
individual child at point of admission and the study was
approved by Kenyan National Scientific and Ethical
Review Board.
Study participants and definitions
For the purpose of this study, we defined a neonate as
any child admitted aged 28 days or younger [23]. Sei-
zures were defined as reported or observed repeated
involuntary muscle contractions, abnormal tonic exten-
sions or jerky movements of any part of the limb, face
or mouth that was not stimulus sensitive or repetitive
abnormal chewing, ocular or pedalling movements.
The discharging clinician made the final diagnosis (for
example, neonatal sepsis, neonatal encephalopathy or
prematurity) after review of the admission history,
inpatient management notes and laboratory investiga-
tions. These diagnoses were checked by a supervising
clinician and followed the current World Health Orga-
nization (WHO) guidelines for the management of
common illnesses in hospitals with limited resources
[10]. The diagnoses are outlined in Appendix 1. A defi-
nite diagnosis of invasive bacterial disease was made
upon isolation of pathogenic organisms from blood
culture or cerebrospinal fluid (CSF). Otherwise sepsis
was considered as the possible diagnosis in any new-
born presenting with any one of the following signs:
abnormal temperature (>37.5°C or <35.5°C) and multi-
ple skin pustules, umbilical redness or pus, respiratory
distress, lethargy, seizures or feeding problems [10].
Meningitis was defined as positive CSF culture or a
white cell count of >50/μL in CSF or a positive bacter-
ial antigen test or gram stain [24]. Prematurity was
considered in any neonate born before 37 completed
weeks if the last date of monthly period was known or
in infants whose estimated gestation was less than 37
completed weeks [25]. Neonatal encephalopathy was
considered in any newborn who had history of a poor
Apgar score (<7) at 5 min (if delivered in hospital)
with accompanying history and signs such as poor cry,
feeding problems, restlessness, agitation, hypotonia,
hypertonia, seizures and coma, or similar symptoms
and signs after excluding other possible causes for the
home-birth admissions. A diagnosis of neonatal jaun-
dice was made when the total plasma bilirubin levels
(as measured by the Neobil, Schuco International, Lon-
don, UK, 2005) were elevated above an established
threshold for phototherapy for the age, gestation,
weight and clinical features [26]. We considered any
neonate presenting with trismus or spasms occurring
on stimulation or spontaneously with or without feed-
ing difficulties to have neonatal tetanus. Since we
recorded up to two final diagnoses recorded at dis-
charge or death using all available clinical, laboratory
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diagnoses may overlap or exceed 100%.
Admission procedures
At admission, the clinician performed emergency care
procedures such as correction of hypothermia, hypoxae-
mia, hypoglycemia and hypovolemia before taking a for-
mal admission history. The history included the number
and where possible a parental description of the seizure
types and interventions already offered. The physical
exam included a formal assessment of the gestational
age [25], determination of a p o s s i b l es i t eo fi n f e c t i o n
and any injuries. A venous blood sample was drawn
(according to weight but not exceeding 3 mL) for a full
blood count, blood glucose, electrolytes and microbiolo-
gical culture. Hypokalaemia was defined as plasma
K
+<3.0 mmol/L, hyperkalaemia as K
+>5.0 mmol/L,
hyponatraemia (moderate-severe) as Na
+<125 mmol/L
and impaired renal function as plasma creatinine >80
μmol/L. Hypoglycaemia was considered in any child
with a blood glucose <3 mmol/L. As part of the WHO
guidelines, meningitis was considered in all neonates
presenting with any one of: drowsiness, lethargy,
reduced feeding, high pitched cry, irritability, apneic epi-
sodes, a bulging fontanel, unconsciousness or seizures
and, where not contraindicated, a lumbar puncture was
performed [10]. All received empirical antibiotic treat-
ment (penicillin and gentamicin). A change of antibio-
tics and the duration of treatment were guided by the
results of culture and the clinical response. There were
no facilities to identify viral causes of meningo-
encephalitis.
Data management and statistical considerations
Admitting clinicians entered individual patient clinical
data at point of contact using a FileMaker Pro database
(5.5v1 Developer, FileMaker Inc, CA, USA). Likewise,
laboratory data was double entered and verified using Fox-
Pro for windows (FoxPro 2.5b for Windows, Microsoft
Corporation, WA, USA). We used Stata 9.2 (Stata Corp,
Texas, USA) for the final analysis. In order to calculate the
incidence of neonatal seizures, the denominator, the popu-
lation of live births (total and by gender) in the demo-
graphic surveillance area at the mid-point of the study (1
st
July 2005) was estimated to be 708 of whom 339 were
males. The estimate was based on a log-linear regression
model of re-enumeration points dated between 27
th April
2001 and 30
th June 2007. The rates are expressed as events
per 1000 live births per year. We then compared the clini-
cal and laboratory features in newborns with and without
seizures to describe the clinical risk and aetiological factors
for neonatal seizures. We used Pearson’s chi square test
(or Fisher’s exact test as appropriate) to compare propor-
tions. We compared the medians of skewed data using the
Mann Whitney-Wilcoxon’s rank-sum test and applied the
Mantel-Haenszel estimate to quantify the effect of seizures
on inpatient death while controlling for weight. Data is
presented with crude odds ratios (OR) and a P-value <
0.05 was considered significant. In order to determine the
risk factors independently associated with seizures, we
entered clinical and laboratory parameters with a P-value
< 0.1 at univariable analysis into a multiple logistic regres-
sion model using a stepwise entry system.
Results
General description
From January 2003 to December 2007 a total of 24,935
children were admitted to the Kilifi District Hospital of
whom 3302 (13.2%) were neonates (age ≤ 28 days, 60%
males). Seizures were reported by parents or carers in
244 (7.4%) of all incident neonatal admissions irrespec-
tive of place of residence (study or non-study area). Of
the 3302 neonates, we excluded 1702 (51%) admissions
from outside of the study area (Figure 1).
Incidence
Among the 1600 neonates identified from the study
area, 28 (1.8%) were readmissions and six of these had
seizures. We excluded these non-incident admissions
from further analysis. One hundred (6%) neonates out
of the 1572 incident admissions from the study area
were admitted with seizures. In addition, another 42
neonates developed seizures after admission to the
ward. Thus, there were a total of 142 (9%) neonates
with seizures among the incident admissions from the
study area. Overall, the incidence of neonatal seizures
was [39.5 ([95% confidence interval - CI - 26.4-56.7)]
per 1000 live births per year. The incidence was [13.6
(95% CI 9.6-17.2)] per 1000 live births in the first 48
hrs, [8.5 (95% CI 6.1-12.3)] per 1000 live births in the
next 2 to 7 days of life and [18.6 (95% CI 15.4-23.0)] in
the rest of the neonatal period. The incidence did not
differ by sex (c
2 = 0.005, P = 0.95).
Two thirds of all neonatal admissions were delivered at
home (out-born) of whom 100/1,047(9.6%) had seizures
compared to 42/525 (8.0%) born in hospital (c
2 = 1.02,
p = 0.31). The prevalence of seizures increased with birth
weight. Seizures were reported in 3/196(1.5%) of neonates
with a birth weight <1.5 kg, in 7/159(4.4%) of those with
weights 1.5-<2.0 kg, 27/238(11%) of those with weights
2.00-2.49 kg and 105/967(11%) of those with a birth
weight ≥ 2.5 kg, (c
2 for trend = 4.92, P < 0.001).
Clinical presentation, laboratory findings and diagnosis
in neonates with seizures
Clinical presentation
Forty six of the 142 neonates (32.3%) had seizures
within the first 48 hrs of life, 30 (21.1%) had seizures on
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occurred after the first week of life. Over 50% of sei-
zures occurred within the first week of life and the
majority of neonates, 79/142 (56%), had more than one
episode within 24 hrs. The median number of seizures
on presentation was three [interquartile range [IQR] 2
to 7). However, there was no significant difference
between the number of seizures among newborns who
died and those discharged alive, (Wilcoxon rank-sum
test, P = 0.34).
Neonates with seizures were older at presentation com-
pared to those without seizures and the median age of
neonates with seizures was 6 (IQR 2 to 15) days com-
pared to 4 (IQR 0 to 11) days for those without seizures,
P < 0.001. Although a history of fever was more common
in newborns presenting with seizures, there was no differ-
ence in the proportion of seizures among those with and
without an axillary temperature of ≥ 37.5°C. The duration
of fever in the two groups was also similar (Table 1).
Laboratory findings
The blood glucose concentration at admission was
documented in 1227 (78%) of the resident and incident
neonatal admissions. Hypoglycaemia was observed in
277/1227 (22.3%) neonates. The proportions with hypo-
glycaemia at admission were similar in those with [23/
125 (18%)] and without seizures [254/1,102 (23%)], c
2 =
1.4, P = 0.24. The proportions of other key laboratory
and clinical characteristics of those with and without
seizures are as shown in (Table 1).
Of the clinical and laboratory features (fever, irritabil-
ity, age, inability to breast feed, bulging fontanel and iso-
l a t i o no fap a t h o g e n i co r g a n i s mi nC S F )t h a tw e r e
associated with seizures on univariable analyses, only
fever, irritability, bulging fontanel and isolation of a
pathogenic organism in CSF were independently asso-
ciated with seizures (Table 1).
Diagnoses
The most frequent discharge diagnosis among neonates
with seizures was neonatal sepsis 85 (60%), followed by
neonatal encephalopathy 30 (21%) and neonatal meningitis
21 (15%) but only a diagnosis of neonatal encephalopathy
or neonatal meningitis were independently associated with
seizures (Table 2). Lumbar puncture (LP) for the evalua-
tion of meningitis was more likely to be performed in neo-
nates presenting with seizures; 107/142 (75%) of neonates
with seizures had a (LP) compared to 569/1430 (40%) of
those without seizures, c
2 =6 7 ,P < 0.001. In addition,
among neonates that had an LP, an infectious agent was
more likely to be isolated in CSF if the neonate presented
with seizures [9/107 (8.4%) compared to 11/569 (1.9%)] of
those without seizures, c
2 =3 1 . 4 ,P < 0.001.
Although sepsis or meningitis was frequently sus-
pected in neonates with seizures, an infective agent in
either blood or CSF was isolated in only 16 of the 142
Figure 1 Neonatal admission to Kenyan District Hospital from January 2003 to December 2007.
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these had isolates grown from CSF. A diagnosis of bac-
terial meningitis was made in 21 (15%) of the cases with
seizures. In nine cases, this was from a positive CSF cul-
ture. The commonest isolates from CSF were Strepto-
coccus pneumoniae (three cases) and non-typhoidal
salmonella (two cases). There was one case each of beta
haemolytic streptococci, S. aureus, Escherichia coli and
Pseudomonas aeroginosa. The diagnosis of meningitis in
the other 12 neonates was based on an elevated CSF
white cell count ≥ 50 μL.
A diagnosis of neonatal encephalopathy was made in
227/1572 (14%) of all incident neonatal admissions from
the study area. A higher proportions [30/227(13.2%)] of
the cases of neonatal encephalopathy had seizures com-
pared to all other diagnosis, [112/1345(8.3%)], c
2 =5 . 7 ,
P = 0.02.
Neonatal encephalopathy was the leading diagnosis in
neonates admitted with seizures within the first 48 h of
life, 28/46 (60.1%). Only two of this had meningitis and
the remaining 16 had neonatal sepsis, three of whom
had culture positive sepsis. After the first 48 h, but
within the first week of life, neonatal sepsis was the pre-
dominant diagnosis. However, meningitis was diagnosed
in six cases. Meningitis was also common after the first
week of life (13/66 [19.7%]) although neonatal sepsis
(43/66 [65.2%]) was still the commonest diagnosis.
Immediate outcome of neonatal seizures
Neonates with seizures had a longer hospitalization. The
median period of inpatient stay among neonates with
seizures was seven (IQR 4 to 10) days compared to five
(IQR 3 to 8) for those without seizures, P = 0.02.
Three hundred of the 1572 (19.1%) neonates died.
Neonates with low admission weight (<2.5 kg) had a
higher case fatality 194/593 (33%), compared to those
weighing (≥ 2.5 kg) 97/967 (10%), c
2 = 125, P < 0.001.
There was no difference in case fatality between







Crude odds ratio [OR
(95 CI)]
P value Adjusted OR
(95% CI)
P Value
Median (interquartile range) age, days 6 (2-15) 4 (0-11) 1.04 (1.01-1.05) 0.002 1.01 (0.99-1.03) 0.44
Males (%) 83 (58.5) 840 (58.7) 1.12 (0.75-1.49) 0.75 - -
Median weight (kg) [95%CI] 2.94 [2.46-3.29] 2.74 [2.04-3.18] 6.21(1.0-38.7) 0.05 1.00(0.99-1.00) 0.52
Fever (%) 75 (52.8) 502 (35.1) 2.14 (1.52-3.03) <0.001 1.63 (1.10-2.43) 0.02
Irritability (%) 11(7.7) 25 (1.7) 4.61 (2.22-9.57) <0.001 2.53 (1.04-6.17) 0.04
Inability to breast feed (%) 36 (25.4) 503 (35.2) 1.58 (1.08-2.33) 0.02 1.13 (0.71-1.81) 0.53
Bulging fontanel (%) 14 (9.9) 16 (1.0) 10.22 (4.9-21.1) <0.001 5.94 (2.65-13.30) <0.001
Hypoglycaemia (%) 23 (16.2) 254 (17.7) 0.91 (0.58-1.44) 0.69 - -
Hyponatraemia (%) 4 (2.8) 43 (2.9) 0.92 (0.32-1.59) 0.87 - -
Hypernatraemia (%) 3 (2.1) 9 (0.6) 3.34 (0.89-12.47) 0.07 - -
Hypokalaemia (%) 12 (8.1) 130 (8.9) 0.90 (0.49-1.67) 0.75 - -
Hyperkalaemia (%) 14 (9.5) 119 (8.2) 1.18 (0.66-2.11) 0.58 - -
Positive cerebral spinal fluid culture (%) 9 (8.4) 11 (1.9) 14.01 (6.01-32.47) <0.001 14.08 (3.60-55.09) <0.001
Positive blood culture (%) 10 (7.0) 76 (5.3) 1.32(0.67-2.61) 0.80 - -
Table 2 Clinical diagnosis and neonatal seizures
Characteristics Incident neonatal admissions with
seizures,




n = 1430 (%)




Neonatal sepsis 89 (62.7) 772 (54.0) 1.27 (0.91-1.80) 0.16
Prematurity 3 (2.1) 248 (17.3) 0.10 (0.03-032) <0.001
Neonatal
encephalopathy
30 (21.1) 197 (13.7) 1.63 (1.06-2.50) 0.03
Neonatal jaundice 17(12.0) 372 (26.0) 0.38 (0.23-0.64) <0.001
Meningitis 21(14.8) 8 (0.6) 34.4 (14.65-76.26) <0.001
Neonatal tetanus 3 (2.1) 18 (1.3) 1.04 (0.48-5.70) 0.42
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2 =0 . 7 6 ,P =0 . 3 8 .
However, if this was stratified by weight, seizures were
associated with higher case fatality in neonates ≥ 2.5 kg
compared to low birth weight infants [<2.5 kg (OR 1.59
[95% CI 1.02 to 2.46), P = 0.037].
Of the 32 deaths in neonates with seizures, 12 (38%)
were suspected to have sepsis and five (16%), meningitis.
However, an infective organism was isolated in only four
of these. Of the remaining babies, eight (25%) had neo-
natal encephalopathy. four had severe neonatal jaundice
and three had tetanus. In addition, seven (22%) children
who died were hypoglycaemic on admission and 14
(44%) had an abnormal core temperature (<36.0°C or
>37.5°C). In total 15 (47%), of the neonates with seizures
who died were low birth weight (<2.5 kg) with three
(10%) weighing <1.5 kg.
On discharge, 14/110 (13%) of the surviving neonates
had an abnormal neurological exam. Of the 14, four had
hydrocephalus, three were discharged on long-term phe-
nobarbital due to recurrent seizures, another three had
a poor sucking reflex and two had spasticity. The
remaining two newborns though not classified as normal
had subtle undefined neurological abnormality. Follow
up through our surveillance system showed that 16/
1271 (9.1%) of all neonates died post-discharge and
there was no difference between those admitted with or
without seizures c
2 = 1.78, P = 0.18.
Discussion
Children living in this rural area of Kenya experience a
very high burden of acute seizure disorders. In a pre-
vious report, we indicated that the minimum incidence
of acute seizures in children 0-13 years of age is as high
as 425 per 100,000/year [14]. Although available data
suggests that children younger than 5 years have an
even higher burden of acute seizure disorders and that
neonatal diseases are major aetiological factors [4,14,27],
the burden and causes of acute neonatal seizure disor-
ders in rural African settings has been poorly documen-
ted [12,14]. In this study, the incidence of neonatal
seizures was 39.5 (95% CI 26.4-56.7) per 1000 live births
and the most common diagnoses associated with sei-
zures were neonatal encephalopathy and meningitis.
The incidence of acute neonatal seizures
The incidence data we describe is the minimum since
not all neonates would have attended the Kilifi District
Hospital. In the earlier study, it was estimated that only
20% of children with seizures in the community may
have been admitted to hospital [14]. It is also worth not-
ing that up to two-thirds of deaths in children <5 years
in this community occur outside the hospital and this
proportion may even be higher among neonates since
the majority are born at home [20,28]. It is plausible
that many neonates with seizures may be dying in the
community before reaching the hospital. Moreover, dis-
tance from hospital also affects hospital attendance [14].
Thus, our data could have greatly underestimated the
i n c i d e n c eo fs e i z u r e si nn e o n a t e si nt h i sc o m m u n i t y .
D e s p i t et h ea b o v ec a v e a t s ,t h es t u d ys u g g e s t st h a tt h e
incidence of neonatal seizures in this setting is much
higher than that reported from developed nations [4,27]
and this may reflect the high prevalence of risk factors
for neonatal brain insult in this community.
Very few other centres in developing countries have
attempted to quantify the burden of neonatal seizures.
Previously, based on a small sample of just 43 neonates,
we estimated the incidence to be 14.0 per 1000 live
births [14]. Similarly In Ethiopia, the incidence was
found to be 13.6 per 1000 live births [12] but the report
only included early onset seizures (those occurring
within 48 hrs of life) which may explain the much lower
incidence. This study, with a longer surveillance period
(5 years) covering the entire neonatal period, may pre-
sent a more accurate estimate of the overall burden of
neonatal seizures in the region.
Diagnoses, inpatient outcome and implications
for public health
Although neonatal sepsis was a common diagnosis, it
was not independently associated with seizures. Impor-
tantly, isolation of a pathogenic organism in blood alone
was not associated with seizures. The two principal
diagnoses associated with seizures were neonatal ence-
phalopathy and meningitis. The increased inpatient case
fatality associated with seizures supports previous
reports [3,5]. However, it is worth noting that this dif-
ference was only significant for the term-weight new-
born. The lack of association between seizures and
death in the low-weight neonates may have been veiled
b yt h ev e r yh i g hc a s ef a t a l i t y( > 3 0 % ) ,e s p e c i a l l yi nt h e
preterm babies.
Although debate continues on whether seizures in the
neonatal period cause brain damage or are just an epi-
phenomenon of insults already sustained from the
underlying pathology, available evidence suggest that
long-term outcome is largely dependent on the cause of
the seizure [3,5]. Our findings, that up to 13% of all
newborn with seizures had neurological abnormalities at
discharge, is supported by community-based studies in
this region that identified neonatal insults as the key
risk factor for moderate and severe neurological impair-
ment [29]. However, higher levels of neurological
abnormalities at discharge and on long-term follow up
have been reported in studies in developed countries
[3-5]. It is plausible that the relatively lower prevalence
of neurological abnormalities on discharge may be a
reflection of the very high inpatient neonatal death.
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to 10%), irrespective of seizures, may have an implica-
tion on prevalence of neurological abnormalities in the
long term.
The two most common diagnoses associated with
neonatal seizures were infections and neonatal encepha-
lopathy. Both conditions are preventable and, using sim-
ple public health interventions, it should be possible to
reduce the burden of neonatal seizures and neonatal
brain injury in the region. Broad measures, such as
ensuring safe deliveries, appropriate neonatal resuscita-
tion and prevention and early treatment of infections in
the newborn period, may reduce this burden [30].
In this study, we were only able to document seizures
that were clinically evident. It is possible that we missed
subclinical seizures and, given the fact that electro-clini-
cal dissociation is more common in neonates than in
other age groups[7], the electroencephalograph monitor-
ing could have led to our further underestimating the
burden of seizures. Secondly, for out-born neonates, the
Apgar scores were not available and so we used the his-
tory and the physical state of the child on admission to
make the diagnosis of neonatal encephalopathy. Thirdly,
neuro-imaging was unavailable and so we are unable to
establish other causes of seizures such intracranial and
periventicular haemorrhages. Fourth, as many of the
b i r t h so c c u r r e da th o m ea n dt h e r ew a sal a c ko fa n y
consistent data on gestational age, we were unable to
examine the effect of gestational age on the prevalence
of seizures and on outcome. Finally, this study did not
examine in detail the long-term outcome of neonates
with seizures.
Conclusion
In conclusion, newborns in this rural area of Kenya have
a high incidence of seizures and neonates with seizures
h a v eal o n g e rh o s p i t a l i z a t i o n ,i n c r e a s e dc a s ef a t a l i t yi n
heavier neonates and neurological deficits on discharge.
The main causes of seizures are birth-related complica-
tions such as neonatal encephalopathy and infections,
especially meningitis. Public health interventions aimed
at ensuring safe deliveries, appropriate neonatal resusci-
tation and prevention of infections in the newborn per-
iod may help to reduce the high incidence. Prospective
studies on the long-term neurological and developmen-
tal outcome following neonatal seizures are needed.
Appendix
Definitions of discharge diagnoses
Invasive bacterial disease: Positive blood or CSF
cultures.
Possible sepsis: Presentation with either one of the
following:
￿ abnormal temperature (>37.5°C or <35.5°C),
￿ multiple skin pustules,
￿ umbilical redness or pus,
￿ respiratory distress, lethargy, seizures or feeding
problems.
Meningiti: Presentation with either one of the follow-
ing:
￿ positive CSF culture,
￿ white cell count of >50/μL in CSF,
￿ positive bacterial antigen test or gram stain.
Prematurity: Documentation of gestation age below
37 completed weeks by:
￿ where last monthly period is known and expected
date of delivery can be calculated,




￿ No cry at birth, poor Apgar score (<7) at 5 min.
￿ An accompanying history of feeding problems,
restlessness, agitation, hypotonia, hypertonia, sei-
zures and coma, or similar symptoms and signs after
excluding other possible.
Neonatal jaundice: Significant total plasma bilirubin
levels for age, weight and clinical picture of newborn
requiring at least phototherapy.
Tetanus:
￿ spasms that may be provoked or spontaneous,
￿ trismus.
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